Thalidezine
Thalidezine is a novel activator of AMP-activated protein kinase (AMPK) . Thalidezine can eliminate anti-apoptotic cancer cells through energy-mediated autophagy death. Thalidezine can be used to study apoptosis intervention [1].
Product Specifications
CAS Number
18251-36-0
UNSPSC
12352005
Target
AMPK; Apoptosis
Type
Natural Products
Related Pathways
Apoptosis; Epigenetics; PI3K/Akt/mTOR
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/thalidezine.html
Solubility
10 mM in DMSO
Smiles
COC1=C(O2)C3=C(CCN(C)[C@@]3([H])CC4=CC=C(OC)C(OC5=CC=C(C=C5)C[C@@]6([H])C7=C(CCN6C)C=C(OC)C2=C7)=C4)C(O)=C1OC
Molecular Formula
C38H42N2O7
Molecular Weight
638.75
References & Citations
[1]Law BYK, et al. Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. Oncotarget. 2017 May 2;8 (18) :30077-30091.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH031583 100 µg
Recombinant Human Frizzled-5/FZD5 Protein (His Tag)
Sign In for Pricing
View Details 
BNUB0954-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (HMPV), 0.2mg/mL
Sign In for Pricing
View Details 